Insert Therapeutics, Inc. Unidym, Inc. Tego BioSciences, Inc. Calando Pharmaceuticals, Inc.

Management Team

Virginia Dadey
Vice President, Investor Relations

Most recently a Senior Vice President of Institutional Sales at Maxim Group LLC, Virginia Dadey has 15 years of experience in financial markets as an investment specialist. Ms. Dadey has developed intimate knowledge of a wide array of nanotech and biotech companies, including emerging players. She brings to Arrowhead a successful track record in nanotech deal-making and a wide network of contacts, including domestic and international analysts and fund managers. Dadey worked for the Maxim Group and its predecessor company, Investec, since 2001. She was a vice president at Gruntal & Co. from 1996 to 2001. She received her B.S. in Nutritional Science from Purdue University.